SC 13G/A | 2024-03-11 | Nuveen Asset Management, LLC | ADMA BIOLOGICS, INC. | 4,955,411 | 2.2% | EDGAR |
SC 13G/A | 2024-03-11 | TIAA CREF INVESTMENT MANAGEMENT LLC | ADMA BIOLOGICS, INC. | 4,955,411 | 2.2% | EDGAR |
SC 13G/A | 2024-03-11 | TEACHERS ADVISORS, LLC | ADMA BIOLOGICS, INC. | 4,955,411 | 2.2% | EDGAR |
SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | ADMA BIOLOGICS, INC. | 6,433,369 | 2.8% | EDGAR |
SC 13G | 2024-02-14 | TIAA CREF INVESTMENT MANAGEMENT LLC | ADMA BIOLOGICS, INC. | 5,062,545 | 2.2% | EDGAR |
SC 13G | 2024-02-14 | TEACHERS ADVISORS, LLC | ADMA BIOLOGICS, INC. | 5,062,545 | 2.2% | EDGAR |
SC 13G | 2024-02-14 | Nuveen Asset Management, LLC | ADMA BIOLOGICS, INC. | 5,062,545 | 2.2% | EDGAR |
SC 13G | 2024-02-13 | VANGUARD GROUP INC | ADMA BIOLOGICS, INC. | 12,891,875 | 5.7% | EDGAR |
SC 13G/A | 2024-01-26 | BlackRock Inc. | ADMA BIOLOGICS, INC. | 17,917,745 | 7.9% | EDGAR |
SC 13G/A | 2023-02-14 | TIAA CREF INVESTMENT MANAGEMENT LLC | ADMA BIOLOGICS, INC. | 5,483,369 | 2.5% | EDGAR |
SC 13G/A | 2023-02-14 | TEACHERS ADVISORS, LLC | ADMA BIOLOGICS, INC. | 5,483,369 | 2.5% | EDGAR |
SC 13G/A | 2023-02-14 | Nuveen Asset Management, LLC | ADMA BIOLOGICS, INC. | 5,483,369 | 2.5% | EDGAR |
SC 13G/A | 2023-02-14 | PERCEPTIVE ADVISORS LLC | ADMA BIOLOGICS, INC. | 11,900,255 | 5.4% | EDGAR |
SC 13G/A | 2023-02-13 | Stonepine Capital Management, LLC | ADMA BIOLOGICS, INC. | 6,940,000 | 3.1% | EDGAR |
SC 13G | 2023-02-03 | BlackRock Inc. | ADMA BIOLOGICS, INC. | 15,101,281 | 6.9% | EDGAR |
SC 13D/A | 2022-12-09 | Caligan Partners LP | ADMA BIOLOGICS, INC. | 10,264,311 | 4.6% | EDGAR |
SC 13G | 2022-06-28 | MILLENNIUM MANAGEMENT LLC | ADMA BIOLOGICS, INC. | 6,254,409 | 3.2% | EDGAR |
SC 13G/A | 2022-02-15 | PERCEPTIVE ADVISORS LLC | ADMA BIOLOGICS, INC. | 11,933,387 | 6.1% | EDGAR |
SC 13G/A | 2022-02-14 | Stonepine Capital Management, LLC | ADMA BIOLOGICS, INC. | 9,911,577 | 5.1% | EDGAR |
SC 13G/A | 2022-02-14 | Consonance Capital Management LP | ADMA BIOLOGICS, INC. | 1,289,481 | 1.4% | EDGAR |